Whales with a lot of money to spend have taken a noticeably bullish stance on Moderna.
Looking at options history for Moderna (NASDAQ:MRNA) we detected 17 trades.
If we consider the specifics of each trade, it is accurate to state that 41% of the investors opened trades with bullish expectations and 41% with bearish.
From the overall spotted trades, 8 are puts, for a total amount of $635,317 and 9, calls, for a total amount of $600,368.
What's The Price Target?
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $100.0 and $175.0 for Moderna, spanning the last three months.
Analyzing Volume & Open Interest
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Moderna's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Moderna's substantial trades, within a strike price spectrum from $100.0 to $175.0 over the preceding 30 days.
Moderna Call and Put Volume: 30-Day Overview
Biggest Options Spotted:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|
MRNA | PUT | SWEEP | NEUTRAL | 06/28/24 | $7.05 | $7.0 | $7.0 | $125.00 | $363.3K | 0 | 519 |
MRNA | CALL | SWEEP | BEARISH | 05/17/24 | $24.45 | $22.75 | $23.6 | $104.00 | $136.8K | 159 | 79 |
MRNA | CALL | SWEEP | BEARISH | 07/19/24 | $4.65 | $4.6 | $4.6 | $145.00 | $98.4K | 11.4K | 293 |
MRNA | PUT | SWEEP | BEARISH | 06/28/24 | $8.95 | $8.65 | $8.91 | $128.00 | $89.2K | 0 | 100 |
MRNA | CALL | TRADE | BEARISH | 06/20/25 | $15.35 | $14.8 | $14.8 | $175.00 | $81.4K | 0 | 61 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
After a thorough review of the options trading surrounding Moderna, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Present Market Standing of Moderna
- Currently trading with a volume of 1,671,221, the MRNA's price is up by 0.02%, now at $128.34.
- RSI readings suggest the stock is currently may be overbought.
- Anticipated earnings release is in 78 days.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Moderna options trades with real-time alerts from Benzinga Pro.
有大量资金可以花的大户对Moderna采取了明显的看涨立场。
查看Moderna(NASDAQ:MRNA)的期权历史记录,我们发现了17笔交易。
如果我们考虑每笔交易的具体情况,可以准确地说,有41%的投资者以看涨的预期开盘,41%的投资者持看跌预期。
在已发现的全部交易中,有8笔是看跌期权,总额为635,317美元,9笔看涨期权,总额为600,368美元。
目标价格是多少?
在评估了交易量和未平仓合约之后,很明显,主要市场走势者正在关注过去三个月中Moderna在100.0美元至175.0美元之间的价格区间。
分析交易量和未平仓合约
评估交易量和未平仓合约是期权交易的战略步骤。这些指标揭示了指定行使价下Moderna期权的流动性和投资者对Moderna期权的兴趣。即将发布的数据可视化了与Moderna的大量交易相关的看涨期权和看跌期权的交易量和未平仓合约的波动,在过去30天内,行使价范围从100.0美元到175.0美元不等。
Moderna 看涨期权和看跌交易量:30 天概览
发现的最大选择:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|
MRNA | PUT | SWEEP | NEUTRAL | 06/28/24 | $7.05 | $7.0 | $7.0 | $125.00 | $363.3K | 0 | 519 |
MRNA | CALL | SWEEP | BEARISH | 05/17/24 | $24.45 | $22.75 | $23.6 | $104.00 | $136.8K | 159 | 79 |
MRNA | CALL | SWEEP | BEARISH | 07/19/24 | $4.65 | $4.6 | $4.6 | $145.00 | $98.4K | 11.4K | 293 |
MRNA | PUT | SWEEP | BEARISH | 06/28/24 | $8.95 | $8.65 | $8.91 | $128.00 | $89.2K | 0 | 100 |
MRNA | CALL | TRADE | BEARISH | 06/20/25 | $15.35 | $14.8 | $14.8 | $175.00 | $81.4K | 0 | 61 |
关于 Moderna
Moderna是一家商业阶段的生物技术公司,成立于2010年,并于2018年12月进行了首次公开募股。该公司的 mRNA 技术通过其 COVID-19 疫苗迅速得到验证,该疫苗于 2020 年 12 月在美国获得授权。截至2023年中期,Moderna在临床试验中有39个mRNA开发候选药物。项目涵盖广泛的治疗领域,包括传染病、肿瘤学、心血管疾病和罕见遗传病。
在对围绕Moderna的期权交易进行了全面审查之后,我们将对该公司进行更详细的审查。这包括评估其当前的市场状况和表现。
Moderna 目前的市场地位
期权交易带来更高的风险和潜在的回报。精明的交易者通过不断自我教育、调整策略、监控多个指标以及密切关注市场走势来管理这些风险。通过Benzinga Pro的实时提醒,随时了解最新的Moderna期权交易。